James V. Caruso, President and CEO at Cellectar Biosciences, Inc. (CLRB), bought 21,740 shares at $1.15 ($25K) on 2020-06-05, disclosed to the SEC on 2020-06-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CLRB | BUY | 2021-03-05 | $9K | — | Filing → |
| CLRB | BUY | 2020-12-28 | $50K | — | Filing → |
| CLRB | BUY | 2018-11-30 | $2K | — | Filing → |